Such partnerships and licensing deals were encouraged by the 1980   and   Acts, and the 1986 Federal Technology Transfer Act. The laws are credited with   the biotechnology industry. But from the beginning, some people questioned whether taxpayers were getting a bad deal. Perhaps the   drug developed from a cooperative research and development agreement   